144 related articles for article (PubMed ID: 16365407)
1. Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival.
Pihlgren M; Friedli M; Tougne C; Rochat AF; Lambert PH; Siegrist CA
J Immunol; 2006 Jan; 176(1):165-72. PubMed ID: 16365407
[TBL] [Abstract][Full Text] [Related]
2. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.
Belnoue E; Pihlgren M; McGaha TL; Tougne C; Rochat AF; Bossen C; Schneider P; Huard B; Lambert PH; Siegrist CA
Blood; 2008 Mar; 111(5):2755-64. PubMed ID: 18180376
[TBL] [Abstract][Full Text] [Related]
3. Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life.
Pihlgren M; Schallert N; Tougne C; Bozzotti P; Kovarik J; Fulurija A; Kosco-Vilbois M; Lambert PH; Siegrist CA
Eur J Immunol; 2001 Mar; 31(3):939-46. PubMed ID: 11241299
[TBL] [Abstract][Full Text] [Related]
4. Expression of stromal cell-derived factor-1/pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34+ human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors.
Ishii T; Nishihara M; Ma F; Ebihara Y; Tsuji K; Asano S; Nakahata T; Maekawa T
J Immunol; 1999 Oct; 163(7):3612-20. PubMed ID: 10490954
[TBL] [Abstract][Full Text] [Related]
5. Physiologic corticosterone oscillations regulate murine hematopoietic stem/progenitor cell proliferation and CXCL12 expression by bone marrow stromal progenitors.
Kollet O; Vagima Y; D'Uva G; Golan K; Canaani J; Itkin T; Gur-Cohen S; Kalinkovich A; Caglio G; Medaglia C; Ludin A; Lapid K; Shezen E; Neufeld-Cohen A; Varol D; Chen A; Lapidot T
Leukemia; 2013 Oct; 27(10):2006-15. PubMed ID: 23680895
[TBL] [Abstract][Full Text] [Related]
6. Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54.
Ellyard JI; Avery DT; Mackay CR; Tangye SG
Eur J Immunol; 2005 Mar; 35(3):699-708. PubMed ID: 15714584
[TBL] [Abstract][Full Text] [Related]
7. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression.
Medina F; Segundo C; Campos-Caro A; González-García I; Brieva JA
Blood; 2002 Mar; 99(6):2154-61. PubMed ID: 11877292
[TBL] [Abstract][Full Text] [Related]
8. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population.
O'Connor BP; Cascalho M; Noelle RJ
J Exp Med; 2002 Mar; 195(6):737-45. PubMed ID: 11901199
[TBL] [Abstract][Full Text] [Related]
9. Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development.
Wu Q; Sun Y; Wang J; Lin X; Wang Y; Pegg LE; Fütterer A; Pfeffer K; Fu YX
J Immunol; 2001 Feb; 166(3):1684-9. PubMed ID: 11160211
[TBL] [Abstract][Full Text] [Related]
10. VCAM-1-positive stromal cells from human bone marrow producing cytokines for B lineage progenitors and for plasma cells: SDF-1, flt3L, and BAFF.
Schaumann DH; Tuischer J; Ebell W; Manz RA; Lauster R
Mol Immunol; 2007 Mar; 44(7):1606-12. PubMed ID: 17067679
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow.
Minehata K; Takeuchi M; Hirabayashi Y; Inoue T; Donovan PJ; Tanaka M; Miyajima A
Int J Hematol; 2006 Nov; 84(4):319-27. PubMed ID: 17118758
[TBL] [Abstract][Full Text] [Related]
12. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression.
Ueda Y; Yang K; Foster SJ; Kondo M; Kelsoe G
J Exp Med; 2004 Jan; 199(1):47-58. PubMed ID: 14707114
[TBL] [Abstract][Full Text] [Related]
13. A genetic lesion that arrests plasma cell homing to the bone marrow.
Erickson LD; Lin LL; Duan B; Morel L; Noelle RJ
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12905-10. PubMed ID: 14555759
[TBL] [Abstract][Full Text] [Related]
14. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.
Odendahl M; Mei H; Hoyer BF; Jacobi AM; Hansen A; Muehlinghaus G; Berek C; Hiepe F; Manz R; Radbruch A; Dörner T
Blood; 2005 Feb; 105(4):1614-21. PubMed ID: 15507523
[TBL] [Abstract][Full Text] [Related]
15. Finding a home for plasma cells--a niche to survive.
Tellier J; Kallies A
Eur J Immunol; 2014 Aug; 44(8):2243-6. PubMed ID: 24989963
[TBL] [Abstract][Full Text] [Related]
16. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4.
D'Apuzzo M; Rolink A; Loetscher M; Hoxie JA; Clark-Lewis I; Melchers F; Baggiolini M; Moser B
Eur J Immunol; 1997 Jul; 27(7):1788-93. PubMed ID: 9247593
[TBL] [Abstract][Full Text] [Related]
17. The effects of microenvironment and internal programming on plasma cell survival.
Minges Wols HA; Ippolito JA; Yu Z; Palmer JL; White FA; Le PT; Witte PL
Int Immunol; 2007 Jul; 19(7):837-46. PubMed ID: 17606982
[TBL] [Abstract][Full Text] [Related]
18. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor.
Honczarenko M; Ratajczak MZ; Nicholson-Weller A; Silberstein LE
J Immunol; 2005 Sep; 175(6):3698-706. PubMed ID: 16148115
[TBL] [Abstract][Full Text] [Related]
19. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity.
Minges Wols HA; Underhill GH; Kansas GS; Witte PL
J Immunol; 2002 Oct; 169(8):4213-21. PubMed ID: 12370351
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells.
Pellegrino A; Ria R; Di Pietro G; Cirulli T; Surico G; Pennisi A; Morabito F; Ribatti D; Vacca A
Br J Haematol; 2005 Apr; 129(2):248-56. PubMed ID: 15813853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
